Haemonetics Corp (HAE)
Haemonetics stock today
Haemonetics closed at $119.65 on October 30, 2026, down 0.12% on the day. Over the past year it returned +139.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $5.44 billion.
| Period | HAE | S&P 500 (SPY) |
|---|---|---|
| 1 month | +13.6% | -0.9% |
| 3 months | +41.1% | +2.1% |
| Year to date | +49.3% | +11.7% |
| 1 year | +139.3% | +12.4% |
| 3 years | +40.9% | +88.5% |
| 5 years | +74.1% | +76.0% |
Key statistics
- Market value
- $5.44B
- P/E (trailing)
- 57.8
- Forward P/E
- 22.1
- Price / sales
- 4.0
- 52-week range
- $49.99 to $122.06
- Next report
- Nov 5, 2026
About Haemonetics
Haemonetics manufactures blood management and plasma collection systems for hospitals and blood banks.
Sector: Health Care
More on Haemonetics
- Financials: revenue, earnings and segmentsRevenue -2% in the year to Mar 2026
- Valuation: P/E history and peersP/E 57.8, median 68.7 at its last 9 year ends
- Returns: what $1,000 became$1,000 ten years ago is $3,610 today
No forecast, no recommendation. This page describes Haemonetics Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.